top of page
Search

Phase I Accreditation Scheme - UK MHRA

The MHRA phase I accreditation scheme is a voluntary scheme for organisations conducting phase I trials, for those conducting first in human (FIH) trials.


The MHRA has provided updated information regarding requirements of the scheme and the associated guidance, along with a new compliance checklist and variation form.

The scheme aims to make sure trials are as safe as possible and to create public confidence in the regulation of phase I clinical trials.


Organisations in the scheme must exceed the basic regulatory good clinical practice (GCP) standards by having additional procedures that include the highest standards for avoiding harm to trial subjects and for handling any medical emergencies.


The guidance on Phase I Accreditation Scheme is in this LINK and about the requirements for Phase I Accreditation scheme in this LINK

Recent Posts

See All

Comments

I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page